Feature Channels: Vaccines

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.

• share
• favorite_border

The contributors are Kazan Federal University, Kazan State Medical Academy, Thapar Institute of Engineering and Technology, and the University of Liverpool.

• share
• favorite_border

• share
• favorite_border

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months.

• share
• favorite_border

Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

• share
• favorite_border

The Food and Drug Administration (FDA) is set to meet on October 26 to discuss the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for children aged five to 11. Ahead of this meeting, Loyola Medicine is taking steps to ensure the health system is prepared to administer Pfizer vaccines to children if approval is granted.

• share
• favorite_border

A new analysis by a researcher at Beth Israel Deaconess Medical Center (BIDMC) finds a link between large gatherings of unvaccinated county residents – both students and non-students – and an increase in COVID-19 infections in the university’s community.

• share
• favorite_border

Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression. It is used as a mood stabilizer and lessens the intensity of manic episodes, with particular benefit in reducing suicidality. While highly effective, the drug requires routine blood monitoring, which can be uncomfortable, expensive, and inconvenient for patients who must travel to clinical labs for frequent blood testing.

• share
• favorite_border

Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.

• share
• favorite_border

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

• share
• favorite_border

• share
• favorite_border

Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.